JP2019525939A5 - - Google Patents

Download PDF

Info

Publication number
JP2019525939A5
JP2019525939A5 JP2019504697A JP2019504697A JP2019525939A5 JP 2019525939 A5 JP2019525939 A5 JP 2019525939A5 JP 2019504697 A JP2019504697 A JP 2019504697A JP 2019504697 A JP2019504697 A JP 2019504697A JP 2019525939 A5 JP2019525939 A5 JP 2019525939A5
Authority
JP
Japan
Prior art keywords
methyl
hydrogen
compound according
disorder
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019504697A
Other languages
English (en)
Japanese (ja)
Other versions
JP7187437B2 (ja
JP2019525939A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/044517 external-priority patent/WO2018023072A2/en
Publication of JP2019525939A publication Critical patent/JP2019525939A/ja
Publication of JP2019525939A5 publication Critical patent/JP2019525939A5/ja
Priority to JP2022128312A priority Critical patent/JP7402284B2/ja
Application granted granted Critical
Publication of JP7187437B2 publication Critical patent/JP7187437B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019504697A 2016-07-29 2017-07-28 化合物および組成物ならびにそれらの使用 Active JP7187437B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022128312A JP7402284B2 (ja) 2016-07-29 2022-08-10 化合物および組成物ならびにそれらの使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662368526P 2016-07-29 2016-07-29
US62/368,526 2016-07-29
PCT/US2017/044517 WO2018023072A2 (en) 2016-07-29 2017-07-28 Compounds and compositions and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022128312A Division JP7402284B2 (ja) 2016-07-29 2022-08-10 化合物および組成物ならびにそれらの使用

Publications (3)

Publication Number Publication Date
JP2019525939A JP2019525939A (ja) 2019-09-12
JP2019525939A5 true JP2019525939A5 (cg-RX-API-DMAC7.html) 2020-09-17
JP7187437B2 JP7187437B2 (ja) 2022-12-12

Family

ID=61012362

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019504697A Active JP7187437B2 (ja) 2016-07-29 2017-07-28 化合物および組成物ならびにそれらの使用
JP2022128312A Active JP7402284B2 (ja) 2016-07-29 2022-08-10 化合物および組成物ならびにそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022128312A Active JP7402284B2 (ja) 2016-07-29 2022-08-10 化合物および組成物ならびにそれらの使用

Country Status (26)

Country Link
US (4) US10196403B2 (cg-RX-API-DMAC7.html)
EP (2) EP4464317A3 (cg-RX-API-DMAC7.html)
JP (2) JP7187437B2 (cg-RX-API-DMAC7.html)
KR (1) KR102811121B1 (cg-RX-API-DMAC7.html)
CN (3) CN110088107B (cg-RX-API-DMAC7.html)
AU (2) AU2017301769B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019001439A8 (cg-RX-API-DMAC7.html)
CA (1) CA3032302A1 (cg-RX-API-DMAC7.html)
DK (1) DK3494119T3 (cg-RX-API-DMAC7.html)
EA (1) EA201990400A1 (cg-RX-API-DMAC7.html)
ES (1) ES2996835T3 (cg-RX-API-DMAC7.html)
FI (1) FI3494119T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20241631T1 (cg-RX-API-DMAC7.html)
HU (1) HUE070203T2 (cg-RX-API-DMAC7.html)
IL (1) IL264446B2 (cg-RX-API-DMAC7.html)
LT (1) LT3494119T (cg-RX-API-DMAC7.html)
MA (1) MA45857A (cg-RX-API-DMAC7.html)
MX (2) MX391221B (cg-RX-API-DMAC7.html)
MY (1) MY199446A (cg-RX-API-DMAC7.html)
PH (1) PH12019500196A1 (cg-RX-API-DMAC7.html)
PL (1) PL3494119T3 (cg-RX-API-DMAC7.html)
PT (1) PT3494119T (cg-RX-API-DMAC7.html)
SG (2) SG10202100724UA (cg-RX-API-DMAC7.html)
SI (1) SI3494119T1 (cg-RX-API-DMAC7.html)
UA (1) UA125519C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018023072A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2996835T3 (en) 2016-07-29 2025-02-13 Sumitomo Pharma America Inc Compounds and compositions and uses thereof
EA201990399A1 (ru) 2016-07-29 2019-07-31 Суновион Фармасьютикалз, Инк. Соединения, композиции и их применение
SG11202000669VA (en) * 2017-08-02 2020-02-27 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof
WO2020087031A1 (en) 2018-10-26 2020-04-30 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
CN109369597B (zh) * 2018-12-28 2022-11-29 陕西师范大学 一种异香豆素类化合物的合成方法
WO2020186165A1 (en) 2019-03-14 2020-09-17 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
CN111122736B (zh) * 2019-12-30 2021-03-12 北京鑫开元医药科技有限公司海南分公司 一种用于检测布瓦西坦中间体中对映异构体的方法
US20240190835A1 (en) * 2021-04-08 2024-06-13 Sunovion Pharmaceuticals Inc. Isochroman derivatives and compositions and uses thereof
MX2023011963A (es) * 2021-04-10 2023-10-19 Sumitomo Pharma Co Ltd Derivado biciclico de piridina.
US12077546B2 (en) 2021-04-10 2024-09-03 Sumitomo Pharma Co., Ltd. Bicyclic pyridine derivative
CN117177977A (zh) * 2021-04-10 2023-12-05 住友制药株式会社 二环吡啶衍生物
CN115677719B (zh) * 2022-10-27 2025-03-07 复旦大学 一种芳基并杂环化合物及其制备方法和用途
CN119263959B (zh) * 2024-12-10 2025-09-05 浙江九洲药业股份有限公司 一种格列齐特中间体1,2-环戊二甲醇的制备方法
CN120518681B (zh) * 2025-07-22 2025-09-12 成都施贝康生物医药科技有限公司 一种化合物及其应用

Family Cites Families (215)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB984365A (en) 1961-10-03 1965-02-24 Ici Ltd Pyrimidine derivatives
US3470179A (en) 1966-06-14 1969-09-30 Sandoz Ag 4-substituted-3,4-dihydroquinazolines
US3549624A (en) 1967-08-17 1970-12-22 Pfizer & Co C 2-substituted-2-delta**2-tetrahydropyrimidines and delta**2-im
US3438995A (en) * 1968-01-08 1969-04-15 Melville Sahyun Diazaheterocyclic substituted benz-oxaheterocyclic compounds
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3551427A (en) 1969-05-09 1970-12-29 Sandoz Ag 4-thienyl-2-(1h)-quinazolones
US4021451A (en) 1972-05-16 1977-05-03 American Home Products Corporation Process for preparing polycyclic heterocycles having a pyran ring
US4036842A (en) 1972-05-16 1977-07-19 American Home Products Corporation Process for preparing polycyclic heterocycles having a pyran ring
US4223151A (en) * 1972-05-16 1980-09-16 American Home Products Corporation Process for preparing polycyclic heterocycles having a pyran ring
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
JPS51125287A (en) * 1974-12-04 1976-11-01 Takeda Chem Ind Ltd Aprocess for preparing heterocyclic compounds
US4021452A (en) 1975-04-23 1977-05-03 American Cyanamid Company 2,5-Dihydro-2,5-dialkoxyfuran derivatives
JPS541910Y2 (cg-RX-API-DMAC7.html) 1975-12-12 1979-01-26
JPS5919549B2 (ja) * 1976-01-01 1984-05-07 武田薬品工業株式会社 異節環状化合物
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
US4127665A (en) 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4556656A (en) * 1978-10-23 1985-12-03 The Upjohn Company 2-Benzoxepins
FR2459239A1 (fr) 1979-06-20 1981-01-09 Logeais Labor Jacques Nouveaux derives amines du benzothiazole, leur procede de preparation et leur application en therapeutique
US4500543A (en) * 1982-06-01 1985-02-19 Abbott Laboratories Substituted 1-aminomethyl-phthalans
US4518779A (en) * 1982-09-27 1985-05-21 Pennwalt Corporation 1,2,3,4-Tetrahydro-1-aminomethyl-4-phenyl isoquinolines
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
PH30676A (en) 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
JPH049367Y2 (cg-RX-API-DMAC7.html) 1986-12-27 1992-03-09
JPS646267A (en) * 1987-02-04 1989-01-10 Daiichi Seiyaku Co 2-benzopyran derivative
US4904300A (en) 1987-08-26 1990-02-27 Ciba-Geigy Corp. Imidazole derivatives
PT90001B (pt) 1988-03-16 1994-06-30 Zambeletti Spa L Processo para a preparacao de derivados heterociclicos de etilenodiamina
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
DE3827727A1 (de) 1988-08-16 1990-02-22 Boehringer Ingelheim Kg Anellierte tetrahydropyridinessigsaeurederivate, verfahren zu deren herstellung und verwendung solcher verbindungen zur kardioprotektion
GB8824400D0 (en) 1988-10-18 1988-11-23 Glaxo Group Ltd Chemical compounds
EP0368175A1 (de) 1988-11-06 1990-05-16 Boehringer Ingelheim Kg 3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
GB8827479D0 (en) 1988-11-24 1988-12-29 Zambeletti Spa L Novel compounds
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US4963568A (en) * 1989-05-31 1990-10-16 Abbott Laboratories Dopamine agonists
US5621133A (en) 1989-05-31 1997-04-15 Deninno; Michael P. Dopamine agonists
US4994486A (en) 1989-05-31 1991-02-19 Abbott Laboratories Dopaminergic compounds
EP0416740A3 (en) 1989-08-08 1991-08-28 Beecham Group P.L.C. Novel compounds with renin-inhibiting activity
JPH0735373B2 (ja) 1989-08-11 1995-04-19 三共株式会社 カルボン酸アミド化合物
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
GB8926560D0 (en) 1989-11-24 1990-01-17 Zambeletti Spa L Pharmaceuticals
DE3940477A1 (de) 1989-12-07 1991-06-13 Bayer Ag Hetaryl-substituierte pyridinylpyrimidin-derivate
US5032598A (en) 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
GB8927872D0 (en) 1989-12-08 1990-02-14 Beecham Group Plc Pharmaceuticals
US5420151A (en) 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
JPH03223277A (ja) 1989-12-29 1991-10-02 Yoshitomi Pharmaceut Ind Ltd ベンゾチオフェン誘導体
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
JPH0735373Y2 (ja) 1990-02-22 1995-08-09 松下電器産業株式会社 トランス
ZA912744B (en) 1990-03-23 1992-02-26 Zambeletti Spa L Pharmaceuticals
JPH049367A (ja) 1990-04-26 1992-01-14 Zeria Pharmaceut Co Ltd アリールアルカノイル誘導体,該化合物の製造中間体及びそれらを含有する医薬
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5238939A (en) 1990-05-25 1993-08-24 Akzo N.V. Isochromane derivatives
GB9018139D0 (en) 1990-08-17 1990-10-03 Pfizer Ltd Therapeutic agents
NZ240155A (en) 1990-10-29 1992-10-28 Ishihara Sangyo Kaisha Heterocyclyl acyl and (hexahydro) indanyl acyl substituted hydrazine derivatives, preparation thereof and pesticidal compositions
DE4104257A1 (de) 1991-02-13 1992-08-20 Boehringer Ingelheim Kg Verwendung von anellierten tetrahydropyridinessigsaeurederivaten fuer die behandlung neurologischer erkrankungen
GB9104839D0 (en) 1991-03-07 1991-04-17 Zambeletti Spa L Novel compounds
JPH0826011B2 (ja) * 1991-04-25 1996-03-13 アサヒビール株式会社 アミノメチルイソクロマン誘導体およびその製造方法
NZ243065A (en) 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
US5288749A (en) * 1991-12-20 1994-02-22 Abbott Laboratories Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
PH31294A (en) 1992-02-13 1998-07-06 Thomae Gmbh Dr K Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and process for preparing them.
JP3223277B2 (ja) 1992-04-10 2001-10-29 カシオ計算機株式会社 楽音制御装置
FR2692264B1 (fr) 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
IT1255178B (it) 1992-06-26 1995-10-20 Pierrel Spa N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica,dopaminergica e adrenergica
EP0600836B1 (de) 1992-12-02 1998-08-05 Novartis AG Selektiv-herbizides Mittel
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
TW334423B (en) 1993-10-22 1998-06-21 Hoffmann La Roche Tricyclic 1-aminoethylpyrrole-derivatives
JP3163068B2 (ja) 1993-12-27 2001-05-08 日本建工株式会社 野縁取付け金具
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
FR2723091B1 (fr) 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
WO1996038435A1 (en) * 1995-05-30 1996-12-05 Abbott Laboratories Dopamine agonists
FR2734819B1 (fr) 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant
SE9702563D0 (sv) 1997-07-02 1997-07-02 Astra Ab Compounds
DE19751949A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
EP1080068A1 (en) 1998-03-12 2001-03-07 Novo Nordisk A/S Modulators of protein tyrosine phosphatases
WO1999046267A1 (en) 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
KR20010041814A (ko) 1998-03-12 2001-05-25 온토젠 코포레이션 단백질 티로신 포스파타제(ptpases)의 조절제
US6262044B1 (en) 1998-03-12 2001-07-17 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (PTPASES)
DE19817265A1 (de) 1998-04-18 1999-10-21 Bayer Ag Verwendung von Dihydropyrimidinen als Arzneimittel und neue Stoffe
DE19817262A1 (de) 1998-04-18 1999-10-21 Bayer Ag Neue 2-heterocyclisch substituierte Dihydropyrimidine
JP2002519348A (ja) 1998-06-30 2002-07-02 イーライ・リリー・アンド・カンパニー 5−ht1fアゴニスト
JP2002527516A (ja) 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ 新規化合物、それらの製造及び使用
IL143577A0 (en) 1998-12-14 2002-04-21 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE60028538T2 (de) 1999-01-19 2007-06-21 Neurosearch A/S Kondensierte heterocyclische verbindungen und ihre verwendung zur behandlung von neurodegenerativen erkrankungen
US6313309B1 (en) 1999-04-05 2001-11-06 Ortho-Mcneil Pharmaceutical, Inc. 4-thionaphthyl—1H—imidazoles which are usefulα22-adrenoceptoR agonists/ antagonists
WO2000068230A1 (en) 1999-05-05 2000-11-16 Darwin Discovery Limited 9-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,9-dihydropurin-6-one derivatives as pde7 inhibitors
GB9914025D0 (en) 1999-06-17 1999-08-18 Zeneca Ltd Chemical compounds
WO2001017516A2 (en) 1999-09-10 2001-03-15 Novo Nordisk A/S Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
EP1214325B1 (en) 1999-09-10 2005-11-09 Novo Nordisk A/S MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
AU7961200A (en) 1999-10-29 2001-05-14 Kaken Pharmaceutical Co., Ltd. Urea derivative, process for producing the same, and medicine containing the urea derivative
AR030537A1 (es) 1999-11-05 2003-08-27 Abbott Lab Acidos quinolincarboxilicos y naftiridincarboxilico antibacterianos
PL203805B1 (pl) 2000-02-25 2009-11-30 Hoffmann La Roche Zastosowanie cyklicznych związków heteroaromatycznych, lek i cykliczne związki heteroaromatyczne
NZ521068A (en) 2000-03-29 2005-04-29 Cyclacel Ltd 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
MXPA02010552A (es) 2000-04-26 2003-03-10 Eisai Co Ltd Composicion farmaceutica que promueve la defecacion.
AU2001277731A1 (en) 2000-08-09 2002-02-18 Welfide Corporation Fused bicyclic amide compounds and medicinal use thereof
AU2001286191A1 (en) 2000-09-12 2002-03-26 Sankyo Company, Limited Quinolizine derivatives
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
WO2002066443A2 (en) 2001-02-21 2002-08-29 Ono Pharmaceutical Co., Ltd. 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives
DE60214701T2 (de) 2001-04-13 2007-09-13 Vertex Pharmaceuticals Inc., Cambridge Inhibitoren von c-jun-n-terminalen-kinasen (jnk) und anderen proteinkinasen
WO2002102387A1 (en) 2001-06-18 2002-12-27 H. Lundbeck A/S Treatment of neuropathic pain
ATE284878T1 (de) 2001-07-11 2005-01-15 Lilly Co Eli Pharmazeutische verbindungen mit serotonin rezeptor aktivität
US20040180883A1 (en) 2001-07-11 2004-09-16 Jeremy Gilmore Pharmaceutical compounds with serotonin receptor activity
WO2003035065A1 (en) 2001-10-26 2003-05-01 Aventis Pharmaceuticals Inc Benzimidazoles and analogues and their use as protein kinases inhibitors
JP2003261566A (ja) 2002-03-11 2003-09-19 Sankyo Co Ltd キノリジンを含有する医薬
DE60325956D1 (de) 2002-04-10 2009-03-12 Dongbu Hitek Co Ltd Benzopyranderivate, die mit sekundären aminen einschliesslich tetrazol substituiert sind, verfahren etzungen, die diese enthalten
TW200306783A (en) 2002-04-29 2003-12-01 Fmc Corp Pesticidal heterocycles
US7323485B2 (en) 2002-05-21 2008-01-29 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
US7358269B2 (en) 2002-05-21 2008-04-15 Allergan, Inc. 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one
US7091232B2 (en) 2002-05-21 2006-08-15 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
US7276522B2 (en) 2002-05-21 2007-10-02 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
SE0202134D0 (sv) 2002-07-08 2002-07-08 Astrazeneca Ab Therapeutic agents
EP1554394B1 (en) 2002-10-16 2009-12-16 Isis Innovation Limited Screening methods using a structural model of FIH
US20060241130A1 (en) 2003-01-31 2006-10-26 Ehud Keinan Anti-inflammatory compositions and uses thereof
EP2527326B1 (en) 2003-03-07 2014-10-08 Santen Pharmaceutical Co., Ltd Novel compounds having 4-pyridylalkylthio group as substituent
JP2004269449A (ja) 2003-03-11 2004-09-30 Ishihara Sangyo Kaisha Ltd ベンズアミド誘導体、それらの製造方法及びそれらを含有する有害生物防除剤
US7205318B2 (en) 2003-03-18 2007-04-17 Bristol-Myers Squibb Company Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors
JP2006522109A (ja) 2003-03-31 2006-09-28 大正製薬株式会社 新規なキナゾリン誘導体及びそれらの使用に関連する治療方法
PT1613315E (pt) 2003-04-04 2009-04-22 Novartis Ag Derivados da quinolina-2-ona para o tratamento de doenças das vias aéreas respiratórias
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
WO2004112719A2 (en) 2003-06-19 2004-12-29 Smithkline Beecham Corporation Chemical compounds
US20050032873A1 (en) 2003-07-30 2005-02-10 Wyeth 3-Amino chroman and 2-amino tetralin derivatives
DE10347385A1 (de) 2003-10-08 2005-05-12 Schering Ag Umgelagerte Pentanole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
JP2005145859A (ja) 2003-11-13 2005-06-09 Nippon Steel Chem Co Ltd 脱水素化方法及び芳香族複素環化合物の製造方法
DE10360793A1 (de) 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
EP1715855A4 (en) 2004-01-29 2010-06-16 Elixir Pharmaceuticals Inc ANTIVIRAL DRUGS
DE102004004974A1 (de) 2004-01-31 2005-08-18 Aventis Pharma Deutschland Gmbh Thieno-Iminosäure-Derivate als Inhibitoren von Matrix-Metalloproteinasen
GB0403155D0 (en) 2004-02-12 2004-03-17 Vernalis Res Ltd Chemical compounds
WO2005087714A2 (en) 2004-03-09 2005-09-22 Elan Pharmaceuticals, Inc. Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors
KR100553398B1 (ko) 2004-03-12 2006-02-16 한미약품 주식회사 티에노[3,2-c]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
JP2007530583A (ja) 2004-03-25 2007-11-01 イーラン ファーマスーティカルズ、インコーポレイテッド 2−アミノ−及び2−チオ置換されている1,3−ジアミノプロパン
ES2342083T3 (es) 2004-04-29 2010-07-01 Aventis Pharmaceuticals Inc. 3-piperidinilisocroman-5-oles como agonistas de dopamina.
AU2005267798A1 (en) 2004-07-28 2006-02-09 Irm Llc Compounds and compositions as modulators of steroid hormone nuclear receptors
SE0401970D0 (sv) 2004-08-02 2004-08-02 Astrazeneca Ab Novel compounds
SE0401971D0 (sv) 2004-08-02 2004-08-02 Astrazeneca Ab Piperidne derivatives
EP1634873A1 (en) 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
FR2875230A1 (fr) 2004-09-13 2006-03-17 Sanofi Aventis Sa Derives de pyrazole condense, leur preparation et leur application en therapeutique
JP2006117568A (ja) 2004-10-20 2006-05-11 Mitsubishi Pharma Corp チオフェン環を有する新規アミド誘導体及びその医薬としての用途
US7214704B2 (en) 2004-11-15 2007-05-08 Bristol-Myers Squibb Company 2-Amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
WO2006066172A1 (en) 2004-12-17 2006-06-22 Amgen, Inc. Aminopyrimidine compounds and methods of use
DE102004063227A1 (de) 2004-12-22 2006-07-06 Schering Ag Tricylische Aminoalkohole, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
TW200640931A (en) 2005-02-17 2006-12-01 Wyeth Corp Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
US7884109B2 (en) 2005-04-05 2011-02-08 Wyeth Llc Purine and imidazopyridine derivatives for immunosuppression
TW200716595A (en) 2005-04-22 2007-05-01 Wyeth Corp Chromane and chromene derivatives and uses thereof
RU2382781C2 (ru) 2005-04-22 2010-02-27 Дайити Санкио Компани, Лимитед Гетероциклическое соединение
AU2006243244A1 (en) 2005-05-04 2006-11-09 F. Hoffmann-La Roche Ag (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-HT receptor
CN101228121A (zh) * 2005-05-23 2008-07-23 阿斯利康(瑞典)有限公司 调节5ht6受体的新的8-磺酰基-3-氨基取代的苯并二氢吡喃或四氢化萘衍生物
WO2007001939A1 (en) 2005-06-27 2007-01-04 Janssen Pharmaceutica N.V. Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities
EP1896515A4 (en) 2005-06-27 2010-03-10 Du Pont ELECTRICALLY CONDUCTIVE POLYMER COMPOSITIONS
US20100168102A9 (en) 2005-07-11 2010-07-01 Devgen Nv Amide Derivatives as Kinase Inhibitors
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
TW200800201A (en) 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
US7745484B2 (en) 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
WO2007095586A2 (en) 2006-02-14 2007-08-23 The Trustees Of Columbia University In The City Of New York Neuronal pain pathway modulators
WO2007102999A2 (en) 2006-02-21 2007-09-13 Ampla Pharmaceuticals Inc. Cb1 antagonists and inverse agonists
EP1829869A1 (en) 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
EP2004659A1 (en) 2006-04-12 2008-12-24 Wyeth Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
EP2017275A4 (en) 2006-04-28 2011-06-22 Eisai R&D Man Co Ltd BENZISOXAZOLE COMPOUND
WO2008011560A2 (en) 2006-07-20 2008-01-24 Mehmet Kahraman Benzothiophene inhibitors of rho kinase
WO2008042422A2 (en) 2006-10-04 2008-04-10 Schering Corporation Bicyclic and tricyclic derivatives as thrombin receptor antagonists
US7960569B2 (en) 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
WO2008058342A1 (en) 2006-11-15 2008-05-22 Genetic Technologies Limited Compounds, compositions and methods for controlling invertebrate pests
WO2009008906A2 (en) 2007-02-06 2009-01-15 The Trustees Of The University Of Pennsylvania Therapeutic compounds for blocking dna synthesis of pox viruses
JP5283846B2 (ja) 2007-02-09 2013-09-04 三菱レイヨン株式会社 成形体とその製造方法
AU2008257436A1 (en) 2007-02-13 2008-12-04 Northeastern University Methods and compositions for improving immune responses
US8012986B2 (en) 2007-04-02 2011-09-06 Hoffmann-La Roche Inc. Pyridine and pyrimidine derivatives as MGLUR2 antagonists
US7598417B2 (en) 2007-04-12 2009-10-06 Allergan, Inc. Substituted fluoroethyl ureas as alpha 2 adrenergic agents
EP1982987A1 (en) 2007-04-16 2008-10-22 Laboratorios del Dr. Esteve S.A. Spiro-pyrano-pyrazole derivatives
EP1982714A1 (en) 2007-04-16 2008-10-22 Laboratorios del Dr. Esteve S.A. Pyrano-pyrazole-amines
EP2020414A1 (en) 2007-06-20 2009-02-04 Laboratorios del Dr. Esteve S.A. spiro[piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis
US8338623B2 (en) 2007-07-09 2012-12-25 Abbvie Inc. Compounds as cannabinoid receptor ligands
WO2009035671A1 (en) 2007-09-12 2009-03-19 Janssen Pharmaceutica N.V. Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine h4 receptor
KR101103118B1 (ko) 2007-11-02 2012-01-04 동아제약주식회사 신규한 1,3-디히드로-5-이소벤조퓨란카르보니트릴 유도체 화합물 및 이를 함유하는 조루증 치료용 약학조성물
US8158792B2 (en) 2007-11-21 2012-04-17 Janssen Pharmaceutica N.V. Spiropiperidines for use as tryptase inhibitors
US7973051B2 (en) 2007-11-30 2011-07-05 Hoffman-La Roche Inc. Aminothiazoles as FBPase inhibitors for diabetes
WO2009072621A1 (ja) 2007-12-07 2009-06-11 Nissan Chemical Industries, Ltd. 置換ジヒドロアゾール化合物及び有害生物防除剤
CN101468986B (zh) 2007-12-26 2010-12-29 香港南北兄弟国际投资有限公司 一种二氢嘧啶消旋化合物的拆分方法
CN101468987B (zh) 2007-12-26 2011-06-08 香港南北兄弟国际投资有限公司 2-杂环取代的二氢嘧啶消旋化合物的拆分方法
WO2009085256A1 (en) 2007-12-27 2009-07-09 Panacos Pharmaceuticals, Inc. Anti-hiv compounds
CN101759710B (zh) 2008-10-06 2011-10-05 山东轩竹医药科技有限公司 含有取代的氮杂环的头孢菌素衍生物
US9776963B2 (en) 2008-11-10 2017-10-03 The Trustees Of The University Of Pennsylvania Small molecule CD4 mimetics and uses thereof
WO2010090716A1 (en) 2009-01-30 2010-08-12 Millennium Pharmaceuticals, Inc. Heteroaryls and their use as pi3k inhibitors
TW201038569A (en) 2009-02-16 2010-11-01 Abbott Gmbh & Co Kg Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
AR075442A1 (es) 2009-02-16 2011-03-30 Abbott Gmbh & Co Kg Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
US8673920B2 (en) * 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
TW201041757A (en) 2009-05-20 2010-12-01 Univ Nat Taiwan Science Tech Method for simulating, fabricating or duplicating an oil painting
US9284307B2 (en) 2009-08-05 2016-03-15 Idenix Pharmaceuticals Llc Macrocyclic serine protease inhibitors
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
UA107943C2 (xx) 2009-11-16 2015-03-10 Lilly Co Eli Сполуки спіропіперидину як антагоністи рецептора orl-1
SI2501704T1 (sl) 2009-11-16 2013-11-29 Eli Lilly Company Spojine spiropiperidina kot antagonisti oral-1 receptorja
SG181498A1 (en) 2009-12-04 2012-07-30 Sunovion Pharmaceuticals Inc Multicyclic compounds and methods of use thereof
AU2010339271B2 (en) 2009-12-28 2015-09-03 General Incorporated Association Pharma Valley Project Supporting Organization 1,3,4-oxadiazole-2-carboxamide compound
AU2011210518A1 (en) 2010-02-01 2012-07-19 Sgl Carbon Se Defensive, ceramic based, applique armor, device for providing anti-projectile armoring protection and process for producing ceramic based projectile armor with hollow geometry
EP2377850A1 (en) 2010-03-30 2011-10-19 Pharmeste S.r.l. TRPV1 vanilloid receptor antagonists with a bicyclic portion
WO2011133729A2 (en) 2010-04-23 2011-10-27 Kineta, Inc. Anti-viral compounds
US8883839B2 (en) 2010-08-13 2014-11-11 Abbott Laboratories Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en) 2010-08-13 2015-06-09 AbbVie Deutschland GmbH & Co. KG Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
MY164910A (en) 2010-12-16 2018-02-15 Hoffmann La Roche Tricyclic pi3k inhibitor compounds and methods of use
JP5715713B2 (ja) 2011-03-10 2015-05-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 可溶性グアニル酸シクラーゼ活性化因子
CN102731574B (zh) 2011-03-30 2016-03-02 中国人民解放军军事医学科学院毒物药物研究所 噻吩并吡啶类α-胺基苄基膦酸酯、其制备方法及用途
WO2013010453A1 (en) 2011-07-15 2013-01-24 Abbott Laboratories Chemoking receptor antagonists
WO2013067248A1 (en) 2011-11-04 2013-05-10 Vertex Pharmaceuticals Incorporated Benzoxazines as modulators of ion channels
CA3132120C (en) 2012-02-08 2023-10-24 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
JP2015520240A (ja) 2012-06-20 2015-07-16 ヴァンダービルト ユニバーシティー Mglur5受容体のアロステリック調節剤としての置換二環式アルコキシピラゾール類似体
PL2920166T3 (pl) 2012-11-13 2017-05-31 Array Biopharma, Inc. Bicykliczne związki mocznika, tiomocznika, guanidyny i cyjanoguanidyny przydatne w leczeniu bólu
US9884844B2 (en) 2012-12-31 2018-02-06 Sunovion Pharmaceuticals, Inc. Heterocyclic compounds and methods of use thereof
JP2014214130A (ja) 2013-04-26 2014-11-17 大正製薬株式会社 ジヒドロイミダゾオキサゾール誘導体を含有する医薬
PL3256476T3 (pl) 2015-02-11 2019-05-31 Pgi Drug Discovery Llc Związki i analogi fuzyjnego dihydro-4h-pirazolo[5,1-c][1,4]oksazynylu w leczeniu zaburzeń oun
EP3256466B9 (en) * 2015-02-11 2022-07-27 Sunovion Pharmaceuticals Inc. 1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders
ES2996835T3 (en) 2016-07-29 2025-02-13 Sumitomo Pharma America Inc Compounds and compositions and uses thereof
EA201990399A1 (ru) 2016-07-29 2019-07-31 Суновион Фармасьютикалз, Инк. Соединения, композиции и их применение
GB2560198B (en) 2017-03-03 2020-10-07 Guala Closures Int B V Tamper evident closure
SG11202000669VA (en) 2017-08-02 2020-02-27 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof
WO2020186165A1 (en) 2019-03-14 2020-09-17 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
US20240190835A1 (en) * 2021-04-08 2024-06-13 Sunovion Pharmaceuticals Inc. Isochroman derivatives and compositions and uses thereof

Similar Documents

Publication Publication Date Title
JP2019525939A5 (cg-RX-API-DMAC7.html)
JP7244504B2 (ja) PI3K-γ阻害剤としての三級ヒドロキシ基で置換された縮合イミダゾール誘導体
HK1217486A1 (zh) 作爲β-分泌酶抑制剂的全氟化环丙基稠合的1,3-恶嗪-2-胺化合物以及其使用方法
JP2019511460A5 (cg-RX-API-DMAC7.html)
JP2017524005A5 (cg-RX-API-DMAC7.html)
JP2009542595A5 (cg-RX-API-DMAC7.html)
JP2018511647A5 (cg-RX-API-DMAC7.html)
JP2016513663A5 (cg-RX-API-DMAC7.html)
JP2015512951A5 (cg-RX-API-DMAC7.html)
JP2014513110A5 (cg-RX-API-DMAC7.html)
JP2019532079A5 (cg-RX-API-DMAC7.html)
JP2008513496A5 (cg-RX-API-DMAC7.html)
JP5916746B2 (ja) 認知障害を処置するためのピリダジン誘導体、組成物、および方法
JP2012521994A5 (cg-RX-API-DMAC7.html)
JP2017531020A5 (cg-RX-API-DMAC7.html)
BR112015023267A2 (pt) composto
JP2015500223A5 (cg-RX-API-DMAC7.html)
JP2018505204A5 (cg-RX-API-DMAC7.html)
JP2015531764A5 (cg-RX-API-DMAC7.html)
US12421197B2 (en) Aminopyrazine derivatives as PI3K-γ inhibitors
RU2015112914A (ru) Бензимидазолы в качестве активных агентов для центральной нервной системы
JO3569B1 (ar) مركبات بروبيل حلقي متحد مع ثيازين-2-أمين كمثبطات انزيم بيتا سكريتاز وطرق استخدامها
JP2019516739A5 (cg-RX-API-DMAC7.html)
JP2013525356A5 (cg-RX-API-DMAC7.html)
JP2018511627A5 (cg-RX-API-DMAC7.html)